(Q37798692)

English

Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer

scientific article published on February 2011

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

23 August 2017

Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer (English)

1 reference

stated in

Europe PubMed Central

23 August 2017

1 reference

Kazuhiko Ino

1

1 reference

stated in

Europe PubMed Central

PubMed ID

20930628

retrieved

23 August 2017

language of work or name

1 reference

1 February 2011

1 reference

stated in

Europe PubMed Central

23 August 2017

Current Opinion in Obstetrics and Gynecology

1 reference

stated in

Europe PubMed Central

23 August 2017

23

1 reference

stated in

Europe PubMed Central

23 August 2017

1

1 reference

stated in

Europe PubMed Central

23 August 2017

13-18

1 reference

stated in

Europe PubMed Central

23 August 2017

Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.1084/JEM.20020052

Identifiers

DOI

10.1097/GCO.0B013E3283409C79

1 reference

stated in

Europe PubMed Central

23 August 2017

1 reference

Europe PubMed Central

PubMed ID

20930628

retrieved

23 August 2017

(Q37798692)

Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)